Page 148 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

Chapter 4
References
1. McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers.
Nov 19 2015;1:15071. doi:10.1038/nrdp.2015.71
2. Blagojevic C, Heung T, Theriault M, et al. Estimate of the contemporary live-birth prevalence of
recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening.
CMAJ Open. Jul-Sep 2021;9(3):E802-e809. doi:10.9778/cmajo.20200294
3. Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome.
Am J Med Genet A. Nov 1 2005;138(4):307-13. doi:10.1002/ajmg.a.30984
4. Campbell IM, Sheppard SE, Crowley TB, et al. What is new with 22q? An update from the 22q and
You Center at the Children’s Hospital of Philadelphia. Am J Med Genet A. Oct 2018;176(10):2058-
2069. doi:10.1002/ajmg.a.40637
5. Schneider M, Debbané M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood
in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior
in 22q11.2 Deletion Syndrome. Am J Psychiatry. Jun 2014;171(6):627-39. doi:10.1176/appi.
ajp.2013.13070864
6. Boot E, Bassett AS, Marras C. 22q11.2 Deletion Syndrome-Associated Parkinson’s Disease. Mov
Disord Clin Pract. Jan 2019;6(1):11-16. doi:10.1002/mdc3.12687
7. Verheij E, Derks LSM, Stegeman I, Thomeer H. Prevalence of hearing loss and clinical otologic
manifestations in patients with 22q11.2 deletion syndrome: A literature review. Clin Otolaryngol. Dec
2017;42(6):1319-1328. doi:10.1111/coa.12874
8. Persson C, Friman V, Óskarsdóttir S, Jönsson R. Speech and hearing in adults with 22q11.2 deletion
syndrome. Am J Med Genet A. Dec 2012;158a(12):3071-9. doi:10.1002/ajmg.a.35589
9. Golub JS, Brickman AM, Ciarleglio AJ, Schupf N, Luchsinger JA. Association of Subclinical Hearing
Loss With Cognitive Performance. JAMA Otolaryngol Head Neck Surg. Jan 1 2020;146(1):57-67.
doi:10.1001/jamaoto.2019.3375
10. Golub JS, Brickman AM, Ciarleglio AJ, Schupf N, Luchsinger JA. Audiometric Age-Related Hearing
Loss and Cognition in the Hispanic Community Health Study. J Gerontol A Biol Sci Med Sci. Feb 14
2020;75(3):552-560. doi:10.1093/gerona/glz119
11. Zarchi O, Attias J, Raveh E, Basel-Vanagaite L, Saporta L, Gothelf D. A comparative study of hearing
loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23
deletion) syndromes. J Pediatr. Feb 2011;158(2):301-6. doi:10.1016/j.jpeds.2010.07.056
12. Schmidt CM, Bartholomäus E, Deuster D, Heinecke A, Dinnesen AG. [The “Muenster classification”
of high frequency hearing loss following cisplatin chemotherapy]. Hno. Apr 2007;55(4):299-306. Die
“Münsteraner Klassifikation”: Eine neue Einteilung der Hochtonschwerhörigkeit nach Cisplatingabe.
doi:10.1007/s00106-005-1368-1
13. Mazzoli M, Camp GUY, Newton V, Declau F, Parving A. Recommendations for the Description of
Genetic and Audiological Data for Families with Nonsyndromic Hereditary Hearing Impairment.
Audiological Medicine. 07/11 2009;1:148-150. doi:10.1080/16513860301713
14. Margolis RH, Heller JW. Screening tympanometry: criteria for medical referral. Audiology.
1987;26(4):197-208. doi:10.3109/00206098709081549
15. ISO. Acoustics — Statistical distribution of hearing thresholds related to age and gender. 2017. 7029:2017
https://www.iso.org/standard/42916.html
16. Van Eynde C, Swillen A, Lambeens E, et al. Prevalence and Nature of Hearing Loss in 22q11.2 Deletion
Syndrome. J Speech Lang Hear Res. Jun 1 2016;59(3):583-9. doi:10.1044/2015_jslhr-h-15-0098
17. Tian C, Johnson KR. TBX1 is required for normal stria vascularis and semicircular canal development.
Dev Biol. Jan 1 2020;457(1):91-103. doi:10.1016/j.ydbio.2019.09.013
18. Loos E, Verhaert N, Willaert A, et al. Malformations of the middle and inner ear on CT imaging
in 22q11 deletion syndrome. Am J Med Genet A. Nov 2016;170(11):2975-2983. doi:10.1002/
ajmg.a.37872
19. Huang Q, Tang J. Age-related hearing loss or presbycusis. Eur Arch Otorhinolaryngol. Aug
2010;267(8):1179-91. doi:10.1007/s00405-010-1270-7
20. Boot E, Butcher NJ, Udow S, et al. Typical features of Parkinson disease and diagnostic
challenges with microdeletion 22q11.2. Neurology. Jun 5 2018;90(23):e2059-e2067. doi:10.1212/
wnl.0000000000005660
21. Van L, Heung T, Malecki SL, et al. 22q11.2 microdeletion and increased risk for type 2 diabetes.
EClinicalMedicine. Sep 2020;26:100528. doi:10.1016/j.eclinm.2020.100528
146